These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26075560)

  • 1. Pulmonary Infection Caused by Mycobacterium shinjukuense.
    Oshima K; Yokouchi H; Minemura H; Saito J; Tanino Y; Munakata M
    Ann Am Thorac Soc; 2015 Jun; 12(6):958-9. PubMed ID: 26075560
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
    van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
    Inoue T; Tanaka E; Sakuramoto M; Maeda Y; Maniwa K; Taguchi Y
    Kekkaku; 2004 Oct; 79(10):573-7. PubMed ID: 15631109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP; Laurenson IF; Hill AT
    Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary disease caused by Mycobacterium xenopi in an Australian man.
    Woolcock WJ; Dawson DJ
    Med J Aust; 1979 Aug; 2(4):175-7. PubMed ID: 514123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
    Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
    Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 10. Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.
    Kumar L; Gupta R; Puri MM; Jaiswal A; Srinath ; Murar A; Behera D
    J Assoc Physicians India; 2011 Nov; 59():733-5. PubMed ID: 22616343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of nontuberculous Mycobacteria, Oman.
    Al-Mahruqi SH; van-Ingen J; Al-Busaidy S; Boeree MJ; Al-Zadjali S; Patel A; Richard-Dekhuijzen PN; van-Soolingen D
    Emerg Infect Dis; 2009 Feb; 15(2):292-4. PubMed ID: 19193276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontuberculous mycobacteria. An underappreciated cause of geriatric lung disease.
    Kennedy TP; Weber DJ
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1654-8. PubMed ID: 8004325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium nebraskense as a cause of nodular pulmonary disease.
    Puthalapattu S; Metersky ML
    Conn Med; 2011 Oct; 75(9):527-9. PubMed ID: 22308639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.
    Hwang SM; Lim MS; Hong YJ; Kim TS; Park KU; Song J; Lee JH; Kim EC
    Tuberculosis (Edinb); 2013 Nov; 93(6):642-6. PubMed ID: 23988279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary disease due to Mycobacterium massiliense.
    Mitra S; Tapadar SR; Banerjee D; Bhattacharjee S; Dey S; Kundu S
    Indian J Chest Dis Allied Sci; 2012; 54(1):53-7. PubMed ID: 22779125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium shinjukuense lung disease that was successfully treated with antituberculous drugs.
    Watanabe K; Shinkai M; Yamaguchi N; Shinoda M; Hara Y; Ishigatsubo Y; Kaneko T
    Intern Med; 2013; 52(23):2653-5. PubMed ID: 24292757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary infection due to Mycobacterium szulgai, a group 2 nontuberculous mycobacterium].
    Nyui M; Katura T; Tanaka K; Yoshida H
    Nihon Kokyuki Gakkai Zasshi; 2001 Dec; 39(12):920-3. PubMed ID: 11875808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex.
    Ahn CH; Ahn SS; Anderson RA; Murphy DT; Mammo A
    Am Rev Respir Dis; 1986 Sep; 134(3):438-41. PubMed ID: 3530069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.